Capula Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.66M Buy
10,500
+1,200
+13% +$1.22M 0.07% 81
2025
Q4
$9.99M Sell
9,300
-6,600
-42% -$6.31M 0.05% 116
2025
Q3
$12.1M Buy
15,900
+14,000
+737% +$10.4M 0.06% 98
2025
Q2
$1.48M Sell
1,900
-600
-24% -$466K 0.01% 148
2025
Q1
$2.06M Buy
2,500
+600
+32% +$499K 0.01% 193
2024
Q4
$1.47M Buy
1,900
+1,100
+138% +$911K 0.01% 121
2024
Q3
$709K Sell
800
-600
-43% -$539K 0.01% 210
2024
Q2
$1.27M Buy
+1,400
New +$1.12M 0.01% 129
2023
Q4
Sell
-2,400
Closed -$1.29M 446
2023
Q3
$1.29M Buy
+2,400
New +$1.24M 0.03% 180
2023
Q2
Sell
-76,900
Closed -$26.4M 630
2023
Q1
$26.4M Sell
76,900
-11,600
-13% -$3.91M 0.32% 63
2022
Q4
$32.4M Buy
88,500
+73,800
+502% +$26.2M 0.44% 56
2022
Q3
$4.75M Sell
14,700
-17,100
-54% -$5.42M 0.06% 267
2022
Q2
$10.3M Buy
+31,800
New +$9.55M 0.18% 140
2021
Q4
Sell
-9,100
Closed -$2.1M 518
2021
Q3
$2.1M Buy
+9,100
New +$2.25M 0.03% 397
2021
Q1
Sell
-20,600
Closed -$3.48M 533
2020
Q4
$3.48M Buy
+20,600
New +$3.08M 0.17% 119
2020
Q2
Sell
-70,100
Closed -$9.72M 397
2020
Q1
$9.72M Sell
70,100
-1,100
-2% -$151K 0.35% 82
2019
Q4
$9.36M Buy
71,200
+56,200
+375% +$6.51M 0.2% 122
2019
Q3
$1.68M Buy
+15,000
New +$1.67M 0.04% 240

Other funds holding LLY

Capula Management's LLY Position: Q1 2026 in Review

Capula Management increased its Eli Lilly (LLY) stake by 891% in Q1 2026, buying an estimated $3.19M and bringing the position to 3,499 shares worth $3.22M. The position accounts for 0.02% of the portfolio, ranked #176.

Capula Management first reported a position in LLY in Q3 2019 and has held it in 17 quarters since. The position peaked at $78.5M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capula Management held 3,499 shares of Eli Lilly worth $3.22M as of Q1 2026.
  • Capula Management bought 3,146 Eli Lilly shares in Q1 2026, an estimated $3.19M.
  • Eli Lilly made up 0.02% of Capula Management's portfolio in Q1 2026, its #176 holding.
  • Capula Management first reported a position in Eli Lilly in Q3 2019 and has held it in 17 quarters since.
  • Capula Management's Eli Lilly position peaked at $78.5M in Q3 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.